AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
The Newsroom
3 items. To interact with these items, press Control-Option-Shift-Right Arrow.
-
-
AdventHealth Graduate Medical Education Program Celebrates 50 Years
-
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Recent Stories at AdventHealthMD
-
How AI and Human Expertise are Working Together at AdventHealth to Improve Patient Care
-
Long-Term Occupational Therapy Helps Low-Income Patients, AHU Faculty Study Finds
-
Unlocking the Secrets of Healthy Aging: How AdventHealth Scientists are Researching the Connection Between Exercise and Brain Health
-
Research Breakthroughs in Health Care That Will Change the World: An Interview with AdventHealth Investigators
-
AdventHealth Scientists Help Develop Blood Test That Detects Indicator of Parkinson’s Disease
-
AdventHealth Physician and Team Become First in the World to Create and Perform New Endoscopic Procedure Allowing a Patient to Eat Normally Again
-
Direct Feedback From Patients Leads to Improved Experiences in Digestive Care
-
Hispanic Heritage Month: Dr. Alexander a Leading Innovator in Clinical Microbiology
-
Dr. Victor Herrera Appointed Chief Clinical Officer